Open AccessHighly Prevalent SARS-CoV-2 Antigenemia in COVID-19 Patients
Author(s) -
Wenyan Zhang,
Wei Liu,
Jiawang Lin,
Jing Jin,
Kuaile Zhao,
Liang Zhu,
Xiuzhen Wang,
Lijie Wang,
Renshu Tang,
Yindi Zhu,
Zhou Wei,
Enqing You,
Lei Zhang,
Xuxiang Liu,
Jiawei Wu,
Lili Chen,
Wenjing Wang,
Qiang Zhang,
Rongbao Gao
Publication year - 2022
Publication title -
infectious diseases and immunity
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2096-9511
pISSN - 2693-8839
DOI - 10.1097/id9.0000000000000057
Subject(s) - asymptomatic , medicine , covid-19 , antibody , guideline , antigen , severity of illness , immunology , disease , virology , infectious disease (medical specialty) , pathology
Many issues, such as severity assessment and antibody responses, remain to be answered eagerly for evaluation and understanding of COVID-19. Immune lesion is one of key pathogenesis of the disease. It would be helpful to understand the disease if an investigation on antigenemia and association was conducted in the patients with SARS-CoV-2 infection.